ATC code B06

From Wikipedia, the free encyclopedia

ATC code B06 Other hematological agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup B06 is part of the anatomical group B Blood and blood forming organs.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QB06.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

B06A Other hematological agents[edit]

B06AA Enzymes[edit]

B06AA02 Fibrinolysin and desoxyribonuclease
B06AA03 Hyaluronidase
B06AA04 Chymotrypsin
B06AA07 Trypsin
B06AA10 Desoxyribonuclease
B06AA55 Streptokinase, combinations

B06AB Heme products[edit]

B06AB01 Hemin

B06AC Drugs used in hereditary angioedema[edit]

B06AC01 C1-inhibitor, plasma derived
B06AC02 Icatibant
B06AC03 Ecallantide
B06AC04 Conestat alfa
B06AC05 Lanadelumab
B06AC06 Berotralstat

B06AX Other hematological agents[edit]

B06AX01 Crizanlizumab
B06AX02 Betibeglogene autotemcel
B06AX03 Voxelotor
B06AX04 Mitapivat


  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code B06". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QB06". WHO Collaborating Centre for Drug Statistics Methodology.